These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 6773903

  • 1. Differences in the susceptibility of various aldose reductases to inhibition. II.
    Kador PF, Kinoshita JH, Tung WH, Chylack LT.
    Invest Ophthalmol Vis Sci; 1980 Aug; 19(8):980-2. PubMed ID: 6773903
    [Abstract] [Full Text] [Related]

  • 2. Susceptibility of aldehyde and aldose reductases of human tissues to aldose reductase inhibitors.
    Srivastava SK, Petrash JM, Sadana IJ, Ansari NH, Partridge CA.
    Curr Eye Res; 1980 Aug; 2(6):407-10. PubMed ID: 6820339
    [Abstract] [Full Text] [Related]

  • 3. Aldose reductases from human retina and bovine lens: dependence of inhibition upon the choice of enzyme substrate.
    Poulsom R.
    Prog Clin Biol Res; 1987 Aug; 232():341-52. PubMed ID: 3112787
    [No Abstract] [Full Text] [Related]

  • 4. Optical spectroscopy as an in vitro method to monitor aldose reductase inhibitors in the lens.
    Lerman S, Megaw J, Gardner K.
    Invest Ophthalmol Vis Sci; 1983 Nov; 24(11):1505-10. PubMed ID: 6417041
    [Abstract] [Full Text] [Related]

  • 5. Human placenta aldose reductase. Forms sensitive and insensitive to inhibition by alrestatin.
    Maragoudakis ME, Wasvary J, Hankin H, Gargiulo P.
    Mol Pharmacol; 1984 May; 25(3):425-30. PubMed ID: 6427599
    [Abstract] [Full Text] [Related]

  • 6. Medical therapy in the prevention of cataract.
    Brown NA, Bron AJ.
    Trans Ophthalmol Soc U K (1962); 1985 May; 104 ( Pt 7)():748-54. PubMed ID: 3938085
    [Abstract] [Full Text] [Related]

  • 7. The distribution of aldose reductase and aldehyde reductase II in different regions of bovine lens.
    Liu S, Das B, Srivastava SK.
    Lens Eye Toxic Res; 1989 May; 6(3):415-30. PubMed ID: 2518623
    [Abstract] [Full Text] [Related]

  • 8. Diabetic complications in lens and nerve and their prevention by sulindac or sorbinil: two novel aldose reductase inhibitors.
    Jacobson M, Sharma YR, Cotlier E, Hollander JD.
    Invest Ophthalmol Vis Sci; 1983 Oct; 24(10):1426-9. PubMed ID: 6413448
    [Abstract] [Full Text] [Related]

  • 9. Aldose reductase inhibition by anti-allergy drugs.
    Kador PF, Sharpless NE, Goosey JD.
    Prog Clin Biol Res; 1982 Oct; 114():243-59. PubMed ID: 6131432
    [No Abstract] [Full Text] [Related]

  • 10. Inhibition kinetics of human kidney aldose and aldehyde reductases by aldose reductase inhibitors.
    Bhatnagar A, Liu SQ, Das B, Ansari NH, Srivastava SK.
    Biochem Pharmacol; 1990 Mar 15; 39(6):1115-24. PubMed ID: 2157439
    [Abstract] [Full Text] [Related]

  • 11. Aldose reductase inhibitors and prevention of galactose cataracts in rats.
    Unakar N, Tsui J, Johnson M.
    Invest Ophthalmol Vis Sci; 1989 Jul 15; 30(7):1623-32. PubMed ID: 2545646
    [Abstract] [Full Text] [Related]

  • 12. [Prevention of rat galactose cataract with topical aldose reductase inhibitor, E-1008].
    Tasaka H, Akagi Y, Yoshikawa T, Ikebe H, Takahashi Y, Chamoto K, Miyamoto Y, Terubayashi H.
    Nippon Ganka Gakkai Zasshi; 1987 Feb 15; 91(2):246-53. PubMed ID: 3111200
    [No Abstract] [Full Text] [Related]

  • 13. Aldose reductase in diabetic cataracts.
    Kinoshita JH, Kador P, Catiles M.
    JAMA; 1981 Jul 17; 246(3):257-61. PubMed ID: 6787220
    [No Abstract] [Full Text] [Related]

  • 14. [Inhibition of rat lens aldose reductase by flavonoids-matteucinol and baicalein].
    Li SZ, Mao WS, Du XY, Liang SW, Hu BR, Ma YQ.
    Yan Ke Xue Bao; 1987 Jun 17; 3(2):93-4, 137. PubMed ID: 3149594
    [No Abstract] [Full Text] [Related]

  • 15. [Inhibition of aldose reductase from the rat lens by flavonoids].
    Xie MZ, Shen ZF.
    Yao Xue Xue Bao; 1986 Oct 17; 21(10):721-4. PubMed ID: 3107341
    [No Abstract] [Full Text] [Related]

  • 16. Raman spectroscopic study of the effect of aldose reductase inhibitor on experimental diabetic cataract.
    Nozawa H, Yaginuma T, Mizuno A.
    Nippon Ganka Gakkai Zasshi; 1988 Jan 17; 92(1):194-201. PubMed ID: 3133929
    [No Abstract] [Full Text] [Related]

  • 17. [Effects of M79175, an aldose reductase inhibitor, on experimental sugar cataracts].
    Ono H, Nozawa Y, Hayano S.
    Nippon Ganka Gakkai Zasshi; 1982 Jan 17; 86(9):1343-50. PubMed ID: 6818854
    [No Abstract] [Full Text] [Related]

  • 18. Pharmacophor requirements of the aldose reductase inhibitor site.
    Kador PF, Sharpless NE.
    Mol Pharmacol; 1983 Nov 17; 24(3):521-31. PubMed ID: 6415401
    [Abstract] [Full Text] [Related]

  • 19. The effect of aldose reductase and its inhibition on sugar cataract formation.
    Kador PF, Akagi Y, Kinoshita JH.
    Metabolism; 1986 Apr 17; 35(4 Suppl 1):15-9. PubMed ID: 3083204
    [Abstract] [Full Text] [Related]

  • 20. [Aldose-reductase inhibitors and cataract formation (author's transl)].
    Keller G, Leuenberger PM.
    Klin Monbl Augenheilkd; 1980 Apr 17; 176(4):514-5. PubMed ID: 6775130
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.